title: Regulatory Reply to the ATMOSPHERE Data Monitoring Committee.
authors.affiliation: Medical Products Agency, Uppsala, Sweden tomas.salmonson@mpa.se.
authors.forename: Tomas
authors.initials: T
authors.lastname: Salmonson
authors.affiliation: European Medicines Agency, London, United Kingdom.
authors.forename: Heidi
authors.initials: H
authors.lastname: Janssen
authors.affiliation: Federal Institute for Drugs and Medical Devices, Bonn, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Sudhop
authors.affiliation: Federal Institute for Drugs and Medical Devices, Bonn, Germany.
authors.forename: Elke
authors.initials: E
authors.lastname: Stahl
mesh_terms: D000577:Amides / Q000009:adverse effects*; D026661:Clinical Trials Data Monitoring Committees; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005650:Fumarates / Q000009:adverse effects*; D006801:Humans; D016032:Randomized Controlled Trials as Topic
chemical_list: D000577:Amides; D005650:Fumarates